Upgrade to SI Premium - Free Trial

Pliant Therapeutics Inc. (PLRX)

1.16 +0.01 (0.87%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Pliant Therapeutics gets FDA Fast Track for PLN-101095 in solid tumors August 18, 2026 8:30 AM - StreetInsider Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors August 18, 2026 8:30 AM - StreetInsider Form SCHEDULE 13G PLIANT THERAPEUTICS, Filed by: ADAR1 Capital Management, LLC August 14, 2026 9:31 PM - SEC Filing Form SCHEDULE 13G/A PLIANT THERAPEUTICS, Filed by: CITADEL ADVISORS LLC August 14, 2026 4:11 PM - SEC Filing Pliant Therapeutics, Inc. (PLRX) Misses Q2 EPS by 2c August 11, 2026 5:10 PM - StreetInsider Form 8-K PLIANT THERAPEUTICS, For: Aug 11 August 11, 2026 4:11 PM - SEC Filing Form 10-Q PLIANT THERAPEUTICS, For: Jun 30 August 11, 2026 4:09 PM - SEC Filing Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results August 11, 2026 4:05 PM - StreetInsider Form 3 PLIANT THERAPEUTICS, For: Jul 09 Filed by: Iannone Robert July 13, 2026 4:33 PM - SEC Filing Form 3 PLIANT THERAPEUTICS, For: Jul 09 Filed by: Borellini Flavia July 13, 2026 4:32 PM - SEC Filing Form 4 PLIANT THERAPEUTICS, For: Jul 09 Filed by: Iannone Robert July 13, 2026 4:32 PM - SEC Filing Form 4 PLIANT THERAPEUTICS, For: Jul 09 Filed by: Borellini Flavia July 13, 2026 4:32 PM - SEC Filing Form 8-K PLIANT THERAPEUTICS, For: Jul 09 July 13, 2026 4:25 PM - SEC Filing Pliant Therapeutics adds two directors with oncology backgrounds July 13, 2026 8:30 AM - StreetInsider Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors July 13, 2026 8:30 AM - StreetInsider Full Article List